We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 97 results
  1. The Neurohypophysis and Urophysis: Ancient Piscine Neurovascular Interfaces

    Vertebrate homoeostasis is regulated by secretion of neurohormones from specialized neuroendocrine neurovascular interfaces such as the...
    Preethi Rajamannar, Iswarya Arokiadhas, ... Jakob Biran in Neuroanatomy of Neuroendocrine Systems
    Chapter 2021
  2. Hormonal axes in Drosophila: regulation of hormone release and multiplicity of actions

    Hormones regulate development, as well as many vital processes in the daily life of an animal. Many of these hormones are peptides that act at a...

    Dick R. Nässel, Meet Zandawala in Cell and Tissue Research
    Article Open access 22 August 2020
  3. Circulating Vasoactive Peptide Urotensin II and Relationships with Cardiovascular Disease

    The human vasoactive peptide urotensin II (UII) has been described as the most potent vasoconstrictor to date. Despite this, the vasoactive effects...
    Isabella Albanese, Adel Schwertani in Biomarkers in Cardiovascular Disease
    Reference work entry 2016
  4. Effect of Different Peptides

    Eschenhagen et al. (1997) developed a method for culturing embryonic cardiomyocytes in a collagen matrix to produce a coherently contracting...
    Michael Gralinski, Liomar A. A. Neves, Olga Tiniakova in Drug Discovery and Evaluation: Pharmacological Assays
    Reference work entry 2016
  5. Circulating Vasoactive Peptide Urotensin II and Relationships with Cardiovascular Disease

    The human vasoactive peptide urotensin II (UII) has been described as the most potent vasoconstrictor to date. Despite this, the vasoactive effects...
    Isabella Albanese, Adel Schwertani in Biomarkers in Cardiovascular Disease
    Living reference work entry 2015
  6. Beginnings at Harpswell, Maine

    John Sterling Kingsley, Chair of Biology at Tufts College, started the seasonal Harpswell Laboratory on Casco Bay, ME, in 1898. The organization and...
    Chapter 2015
  7. Hypothalamic-pituitary-adrenal axis function during perinatal depression

    Abnormal function of the hypothalamic-pituitary-adrenal (HPA) axis is an important pathological finding in pregnant women exhibiting major depressive...

    Phillipe Leff Gelman, Mónica Flores-Ramos, ... Juan Pablo Reyes Grajeda in Neuroscience Bulletin
    Article 02 March 2015
  8. Palosuran Treatment Effective as Bosentan in the Treatment Model of Pulmonary Arterial Hypertension

    Pulmonary arterial hypertension (PAH) is a progressive and fatal disorder that any valuable advance in the management of diseases has crucial...

    Yavuz Pehlivan, Recep Dokuyucu, ... Ahmet Mesut Onat in Inflammation
    Article 07 March 2014
  9. Effect of Different Peptides

    Eschenhagen et al. (1997) developed a method for culturing embryonic cardiomyocytes in a collagen matrix to produce a coherently contracting...
    Michael Gralinski, Liomar A. A. Neves, Olga Tiniakova in Drug Discovery and Evaluation: Pharmacological Assays
    Living reference work entry 2015
  10. Contractile responses to rat urotensin II in resting and depolarized basilar arteries

    The effects of human urotensin II (hUII) on the vascular tone of different animal species has been studied extensively. However, little has been...

    Cristina Porras-González, Juan Ureña, ... María Ángeles Muñoz-Sánchez in Journal of Physiology and Biochemistry
    Article 18 October 2013
  11. Neuropeptides and Peptide Hormones

    Several types of chemical messengers are employed by the nervous system for local or more diffuse signaling. Among these the peptides are the most...
    Chapter 2013
  12. Effectiveness of Palosuran in Bleomycin-Induced Experimental Scleroderma

    Systemic sclerosis (SSc) is a disease characterized by skin and internal organ involvement. There is progressive accumulation of extracellular matrix...

    Tuncer Demir, Ibrahim Turkbeyler, ... Cahit Bagcı in Inflammation
    Article 12 August 2012
  13. The Efficiency of a Urotensin II Antagonist in an Experimental Lung Fibrosis Model

    Pulmonary fibrosis is a chronic disease. Urotensin II (U-II) is a new peptide with angiogenic and profibrotic features. Therefore, we aim to evaluate...

    Ahmet Mesut Onat, Ibrahim Halil Turkbeyler, ... Bunyamin Kisacik in Inflammation
    Article 29 December 2011
  14. Acanthochondria helicoleni sp. nov. (Copepoda, Chondracanthidae) parasitic on Helicolenus lahillei (Scorpaeniformes, Sebastidae) from Argentinean waters

    A new species of a parasitic copepod, Acanthochondria helicoleni sp. nov. (Copepoda, Chondracanthidae), is described and illustrated from specimens...

    Delfina M. P. Cantatore, Juan T. Timi in Acta Parasitologica
    Article 23 October 2010
  15. Urotensin II acutely increases myocardial length and distensibility: potential implications for diastolic function and ventricular remodeling

    Urotensin II (U-II) is a cyclic peptide that may be involved in cardiovascular dysfunction. In the present study, the acute effects of U-II on...

    Ana Patrícia Fontes-Sousa, Carmen Brás-Silva, ... Adelino F. Leite-Moreira in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 14 August 2007
  16. Caudal neurosecretory system of the zebrafish: ultrastructural organization and immunocytochemical detection of urotensins

    The caudal neurosecretory system is described here for the first time in the zebrafish, one of the most important models used to study biological...

    C. Parmentier, J. Taxi, ... A. Calas in Cell and Tissue Research
    Article 21 March 2006
  17. Urotensin II accelerates cardiac fibrosis and hypertrophy of rats induced by isoproterenol

    Aim:

    To study whether urotensin II (UII), a potent vasoconstrictive peptide, is involved in the development of cardiac hypertrophy and fibrogenesis of...

    Yong-gang Zhang, Yu-guang Li, ... Chao-shu Tang in Acta Pharmacologica Sinica
    Article 01 January 2007
  18. Behavioral effects of urotensin-II centrally administered in mice

    Urotensin-II (U-II) receptors are widely distributed in the central nervous system. Intracerebroventricular (i.c.v.) injection of U-II causes...

    Jean-Claude Do-Rego, David Chatenet, ... Jean Costentin in Psychopharmacology
    Article 14 September 2005
  19. Cardiovascular Activity

    Hans Gerhard Vogel in Drug Discovery and Evaluation
    Reference work entry 2007
  20. Urotensin II stimulates plasma extravasation in mice via UT receptor activation

    The peptide urotensin II (U-II) is the cognate ligand of the G-protein coupled receptor UT (formerly GPR14). A role in the regulation of...

    Raffaella Vergura, Valeria Camarda, ... Domenico Regoli in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 23 October 2004
Did you find what you were looking for? Share feedback.